SCHEMBL515312

SCHEMBL515312

Brc1ccc(-c2nnc(-c3ccccc3)n2-c2ccccc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.73
MEN1 O00255 1/20 0.73
KMT2A Q03164 1/20 0.73
AVPR1A P37288 1/20 0.62
HPGD P15428 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 4/20 0.56
HSD17B10 Q99714 4/20 0.56
TSHR P16473 3/20 0.56
LMNA P02545 2/20 0.55
MAPK1 P28482 2/20 0.52
GLA P06280 1/20 0.50
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
OXTR P30559 1/20 0.47
DHFR P00374 1/20 0.46
OPRD1 P41143 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18682230 0.98 RXFP1 (0.75) RXFP1MEN1KMT2AAVPR1AHPGD
SCHEMBL400873 0.94 KMT2A (0.65) RXFP1MEN1KMT2AAVPR1AHPGD
SCHEMBL2744339 0.90 MEN1 (0.60) RXFP1MEN1KMT2AAVPR1AHPGD
SCHEMBL13492089 0.90 RXFP1 (0.65) RXFP1MEN1KMT2AAVPR1AHPGD
SCHEMBL8339889 0.88 AVPR1A (0.78) RXFP1MEN1KMT2AAVPR1AHPGD
SCHEMBL17223082 0.88 RXFP1 (0.61) RXFP1MEN1KMT2AAVPR1AHPGD
SCHEMBL4402535 0.88 AVPR1A (0.78) RXFP1MEN1KMT2AAVPR1AHPGD
SCHEMBL18327898 0.88 AVPR1A (0.70) RXFP1MEN1KMT2AAVPR1AHPGD
SCHEMBL39449 0.88 AVPR1A (0.70) RXFP1MEN1KMT2AAVPR1AHPGD
SCHEMBL17456637 0.87 AVPR1A (0.77) RXFP1MEN1KMT2AAVPR1AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023070700-A1 COMPOUND USING FLUORENE AS CORE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 青岛科技大学 2023-05-04 WO claimed
CN-114014812-A Compound with fluorene as core and preparation method and application thereof 青岛科技大学 2022-02-08 CN claimed
CN-108658877-A A kind of preparation and its application of electron-transporting type material 中国科学院成都有机化学有限公司 2018-10-16 CN claimed
WO-2023160187-A1 CARBAZOLE DERIVATIVE AND USE THEREOF 上海八亿时空先进材料有限公司 2023-08-31 WO disclosed
WO-2023070700-A1 COMPOUND USING FLUORENE AS CORE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 青岛科技大学 2023-05-04 WO disclosed
CN-114014812-A Compound with fluorene as core and preparation method and application thereof 青岛科技大学 2022-02-08 CN disclosed
US-10790451-B2 Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-09-29 US disclosed
US-10790451-B2 Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-09-29 US disclosed
CN-110724124-A Triazole derivatives 株式会社半导体能源研究所 2020-01-24 CN disclosed
CN-107056717-B D-A type organic fluorescence small molecule material and its application in ferric ion detection 吉林大学 2019-07-30 CN disclosed
CN-106632269-B Blue coloured electroluminous compound and its application in organic electroluminescence device 青岛科技大学 2019-05-28 CN disclosed
WO-2009081718-A1 TRIAZOLE DERIVATIVE, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-07-02 WO disclosed
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-25 US disclosed
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-25 US disclosed
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-25 US disclosed
WO-2008143019-A1 TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-27 WO disclosed
WO-2008143019-A1 TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-27 WO disclosed
US-20080286607-A1 Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-20080286607-A1 Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-20080286607-A1 Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090160324-A1 Triazole Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device GRIN3A, TEAD2, TBL3 RXFP1 4555/4885MEN1 3975/4885KMT2A 1412/4885
US-10790451-B2 Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative TYR, TH, YEATS4 RXFP1 4405/4885MEN1 3934/4885KMT2A 1412/4885
US-20080286607-A1 Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative TYR, TH, CYP3A4 RXFP1 4330/4885MEN1 3872/4885KMT2A 1290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.